| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.192 | 29.917 | 34.400 | 30.572 | 33.187 | 26.261 | 37.424 | 23.286 | 27.405 | - |
| Total Income - EUR | 15.192 | 30.134 | 34.400 | 30.572 | 33.187 | 26.507 | 37.424 | 23.286 | 27.405 | - |
| Total Expenses - EUR | 2.378 | 13.874 | 9.697 | 12.693 | 21.570 | 21.997 | 24.869 | 26.378 | 25.394 | - |
| Gross Profit/Loss - EUR | 12.814 | 16.260 | 24.703 | 17.880 | 11.617 | 4.510 | 12.556 | -3.092 | 2.011 | - |
| Net Profit/Loss - EUR | 12.359 | 15.356 | 23.671 | 17.259 | 11.285 | 4.260 | 12.189 | -3.320 | 1.737 | - |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Farmacia Curantur Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 68.886 | 67.960 | 66.810 | 82.083 | 81.260 | 78.887 | 76.384 | 68.685 | 63.955 | - |
| Current Assets | 79.002 | 27.394 | 47.292 | 46.477 | 56.400 | 59.487 | 34.105 | 37.286 | 39.040 | - |
| Inventories | 0 | 0 | 0 | 0 | 1.083 | 0 | 0 | 0 | 0 | - |
| Receivables | 18.415 | 23.698 | 26.376 | 19.374 | 18.995 | 18.634 | 18.224 | 18.995 | 23.435 | - |
| Cash | 47.624 | 3.696 | 20.916 | 27.103 | 36.322 | 40.853 | 15.881 | 18.291 | 15.604 | - |
| Shareholders Funds | 143.168 | 82.378 | 104.655 | 119.993 | 128.954 | 130.769 | 103.884 | 100.886 | 61.884 | - |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | - |
| Debts | 4.720 | 12.976 | 9.578 | 8.567 | 9.496 | 7.605 | 6.605 | 5.237 | 41.262 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Curantur Srl